Obserwuj
Gniewomir Latacz
Gniewomir Latacz
Jagiellonian University Medical College, Faculty of Pharmacy
Zweryfikowany adres z uj.edu.pl - Strona główna
Tytuł
Cytowane przez
Cytowane przez
Rok
Natural selenium particles from Staphylococcus carnosus: Hazards or particles with particular promise?
EC Estevam, S Griffin, MJ Nasim, P Denezhkin, R Schneider, R Lilischkis, ...
Journal of hazardous materials 324, 22-30, 2017
672017
Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2, 5-dioxopyrrolidin-1-yl) propanamides and 2-(2, 5-dioxopyrrolidin-1-yl) butanamides
K Kamiński, M Zagaja, JJ Łuszczki, A Rapacz, M Andres-Mach, G Latacz, ...
Journal of medicinal chemistry 58 (13), 5274-5286, 2015
582015
Novel multitarget-directed ligands aiming at symptoms and causes of Alzheimer’s disease
A Więckowska, T Wichur, J Godyń, A Bucki, M Marcinkowska, A Siwek, ...
ACS chemical neuroscience 9 (5), 1195-1214, 2018
562018
Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2, 5-dioxopyrrolidin-1-yl) propanamide and 2-(2, 5-dioxopyrrolidin-1-yl …
K Kamiński, A Rapacz, JJ Łuszczki, G Latacz, J Obniska, ...
Bioorganic & medicinal chemistry 23 (10), 2548-2561, 2015
542015
Aryl-1, 3, 5-triazine derivatives as histamine H4 receptor ligands
D Łażewska, M Więcek, J Ner, K Kamińska, T Kottke, JS Schwed, ...
European journal of medicinal chemistry 83, 534-546, 2014
522014
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction
T Felicetti, R Cannalire, D Pietrella, G Latacz, A Lubelska, G Manfroni, ...
Journal of medicinal chemistry 61 (17), 7827-7848, 2018
472018
The 1, 3, 5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
G Latacz, A Lubelska, M Jastrzębska-Więsek, A Partyka, MA Marć, ...
International Journal of Molecular Sciences 20 (14), 3420, 2019
442019
Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse
K Popiolek‐Barczyk, D Łażewska, G Latacz, A Olejarz, W Makuch, H Stark, ...
British journal of pharmacology 175 (14), 2897-2910, 2018
442018
In the search for a lead structure among series of potent and selective hydantoin 5‐HT7R agents: The drug‐likeness in vitro study
G Latacz, A Lubelska, M Jastrzębska‐Więsek, A Partyka, A Sobiło, ...
Chemical biology & drug design 90 (6), 1295-1306, 2017
442017
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT7 receptor antagonist: In vitro drug-likeness studies and in vivo pharmacological evaluation
G Latacz, A Lubelska, M Jastrzębska-Więsek, A Partyka, K Kucwaj-Brysz, ...
Bioorganic & medicinal chemistry letters 28 (5), 878-883, 2018
392018
Chlorophenoxy aminoalkyl derivatives as histamine H3R ligands and antiseizure agents
K Kuder, D Łażewska, G Latacz, JS Schwed, T Karcz, H Stark, ...
Bioorganic & medicinal chemistry 24 (2), 53-72, 2016
392016
KA-11, a novel pyrrolidine-2, 5-dione derived broad-spectrum anticonvulsant: its antiepileptogenic, antinociceptive properties and in vitro characterization
K Socała, S Mogilski, M Pieróg, D Nieoczym, M Abram, B Szulczyk, ...
ACS chemical neuroscience 10 (1), 636-648, 2018
382018
Multifunctional hybrid compounds derived from 2-(2, 5-dioxopyrrolidin-1-yl)-3-methoxypropanamides with anticonvulsant and antinociceptive properties
M Abram, M Zagaja, S Mogilski, M Andres-Mach, G Latacz, S Baś, ...
Journal of medicinal chemistry 60 (20), 8565-8579, 2017
342017
The study of cellular cytotoxicity of argireline-an anti-aging peptide.
M Grosicki, G Latacz, A Szopa, A Cukier, K Kieć-Kononowicz
Acta Biochimica Polonica 61 (1), 2014
342014
Selenazolinium salts as “small molecule catalysts” with high potency against ESKAPE bacterial pathogens
K Witek, M Nasim, M Bischoff, R Gaupp, P Arsenyan, J Vasiljeva, M Marć, ...
Molecules 22 (12), 2174, 2017
332017
Aspects of a distinct cytotoxicity of selenium salts and organic selenides in living cells with possible implications for drug design
E Estevam, K Witek, L Faulstich, M Nasim, G Latacz, ...
Molecules 20 (8), 13894-13912, 2015
332015
Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1 H-imidazol-5-yl)-1 H-indole-5-carboxamides, low-basicity 5-HT 7 …
G Latacz, AS Hogendorf, A Hogendorf, A Lubelska, JM Wierońska, ...
MedChemComm 9 (11), 1882-1890, 2018
302018
Novel naphthyloxy derivatives–potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation
D Łażewska, M Kaleta, S Hagenow, S Mogilski, G Latacz, T Karcz, ...
Bioorganic & medicinal chemistry 26 (9), 2573-2585, 2018
292018
Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats
B Sadek, A Saad, G Latacz, K Kuder, A Olejarz, T Karcz, H Stark, ...
Drug design, development and therapy 10, 3879, 2016
292016
Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands
K Szczepańska, T Karcz, S Mogilski, A Siwek, KJ Kuder, G Latacz, ...
European journal of medicinal chemistry 152, 223-234, 2018
282018
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20